期刊文献+

中国北方敬老院男性人群心血管疾病危险因素调查 被引量:5

A survey on risk factors of cardiovascular diseases in male population in nursing homes in northern part of China
暂未订购
导出
摘要 目的了解中国北方敬老院男性人群心血管疾病危险因素流行及其聚集情况。方法 2010年12月到2012年6月对北方地区15个敬老院1269名男性人群进行问卷调查、体格检查和实验室检查。调查其一般状况和心血管病高危因素(包括高血压、肥胖、吸烟、血脂异常、糖尿病)的发生情况。结果北方敬老院男性人群中93.1%有一种及以上的心血管病高危因素,最常见的依次为高血压(71.9%)、超重或肥胖(44.3%)、吸烟(41.8%)、血脂异常(40.1%)、糖尿病(9.4%),60岁以上人群尤其明显;合并两种(及以上)或三种(及以上)患者的比例分别为69.3%和34.5%。结论北方地区敬老院男性人群特别是60岁以上老年人高血压患病率高,并且多数男性人群合并多种心血管疾病危险因素。 Objective To investigate the epidemic and clustering status of risk factors of cardiovascular diseases(CVD) in male population in nursing homes in northern part of China,and provide the evidence for preventing CVD in nursing homes.Methods Male population(n =1269) was given questionnaire survey,physical examination and laboratory tests in 15 nursing homes in northern part of China from Dec.2010 to June,2012.The level 1 status and incidence of risk factors of CVD(including hypertension,obesity,smoking,dyslipidemia and diabetes) were surveyed.Results In male population in nursing homes in northern part of China,there was 93.1% population with one or more risk factors of CVD,including,in order,hypertension(71.9%),overweight or obesity(44.3%),smoking(42.2%),dyslipidemia(40.1%) and diabetes(9.4%) especially in population ≥ 60 years.The proportion of combining with 2 and 3 risk factors were 69.3% and 34.5% respectively.Conclusion The incidence of hypertension in male population in nursing homes in northern part of China was high,especially in ≥ 60,most of them have multiple risk factors of CVD.It indicates that the prevention of CVD is depended on hypertension control and reducing the risk factor of CVD.
出处 《中国循证心血管医学杂志》 2013年第1期57-58,共2页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 心血管疾病 危险因素 敬老院 男性人群 Cardiovascular diseases Risk factors Nursing home Male group
  • 相关文献

参考文献8

  • 1Murray CJ,Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study[J]. Lancet, 1997,349(9061 ): 1269-76.
  • 2中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616. 被引量:4625
  • 3谢蓉蓉,李桂梅,霍美玲,等.腰围/身高比值:预测儿童代谢综合征有效简便的中心性肥胖指标[J].中华内分泌代谢杂志.2004,20(3):272-5.
  • 4International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [EB/OL]. 2005-04-14.
  • 5中国成人超重和肥胖症预防与控制指南.中华人民共和国卫生部疾病控制司,2003:1.
  • 6王陇德.中国居民营养与健康状况调查报告之2002综合报告[M].北京:人民卫生出版社,2005,48-70.
  • 7张雷,崔红月,刘爱萍,胡东生,王培玉.北京市城乡结合部中老年人心血管疾病危险因素及聚集情况分析[J].中国慢性病预防与控制,2010,18(3):238-240. 被引量:19
  • 8周北凡,武阳丰,李莹,张林峰.中国成人代谢综合征腰围切点的研究[J].中华心血管病杂志,2005,33(1):81-85. 被引量:82

二级参考文献21

  • 1Murray C J, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study[J]. Lancet, 1997, 349: 1269-1276.
  • 2Wu Z, Yao C, Zhao D, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring [J]. Circulation, 2001, 103: 462-465.
  • 3Kannel WB, Sorlie P, Gordon T. Labile hypertension: a faulty concept? The Framingham study [ J ]. Circulation, 1980, 61:1183-1187.
  • 4Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults [J]. Circulation, 2004, 110: 1245-1250.
  • 5Mule G, Cottone S, Mongiovi R, et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients [J]. Nutr Metab Cardiovasc Dis, 2006, 16:54-59.
  • 6O'Donnell CJ, Elosua R. Cardiovascular risk factors: insights from Framingham Heart Study [J]. Rev Esp Cardiol, 2008, 61: 299-310.
  • 7Fox C, Coady S, Sorlie P, et al. Trends in cardiovascular complications of diabetes [J]. JAMA, 2004, 292: 2495-2499.
  • 8Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results Ⅱ: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering [J]. JAMA, 1984, 251: 365-374.
  • 9Iori I, Gatati G, Fusco MA, et al. Survey of cardiovascular risk factors in overweight and obese patients (SCOOP Study): six-month chages in risk factor levels and cardiovascular risk [J]. Euro J Inter Med, 2009, 20: 280-288.
  • 10Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the InterAsia Study [J]. Circulation, 2005, 112: 658-665.

共引文献4728

同被引文献44

  • 1李风原,徐玉霞,杨晓飞,刘悦,唐冰霞.贝那普利对原发性高血压患者心脏、肾脏的保护作用[J].陕西医学杂志,2008,37(7):823-824. 被引量:2
  • 2Zhong JC, Yu XY, Huang Y, et al. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res, 2007,74 ( 3 ) : 388 -395.
  • 3王保富.北京某部公安监管干警心血管危险因素分析[J].中国医师杂志,2012,(z1):66-67.
  • 4Tognon G, Berg C, Mehlig K, et al. Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus onobesity, diet and alcohol intake[J]. PLoS One, 2012,7(7):e40878.
  • 5Zhang B, Kawachi E, Matsunaga A, et al. Reactivity of direct assays for low-density lipoprotein (LDL) cholesterol toward charge-modified LDL inhypercholesterolemia[J]. Circ J, 2012,76(9):2241-2248.
  • 6Baker JV, Neuhaus J, Duprez D, et al. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation ofantiretroviral therapy[J]. AIDS, 2011,25(17):2133-2142.
  • 7Hamoud S, Kaplan M, Meilin E, et al. Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levelsof high-density lipoprotein cholesterol[J]. Am J Med Sci, 2013,345(3):195-199.
  • 8Farnier M, Ducobu J, Bryniarski L. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixedhyperlipidemia not controlled by pravastatin monotherapy[J]. Curr Med Res Opin, 2011,27(11):2165-2173.
  • 9Ballantyne CM, Pitt B, Loscalzo J, et al. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy inpatients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin[LUNAR] Trial)[J]. Am J Cardiol, 2013,111(4):506-509.
  • 10Sniderman AD, Islam S, Yusuf S, et al. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study[J]. Atherosclerosis, 2012,225(2):444-449.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部